MARKER THERAPEUTICS, INC. Increase (Decrease) in Other Receivables
MARKER THERAPEUTICS, INC. (MRKR) reported Increase (Decrease) in Other Receivables of $250.08 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-14
- MARKER THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2026-06-30 was $242.18K.
- MARKER THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2026-03-31 was $7.90K, a 92.95% decline year-over-year.
- MARKER THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2025-06-30 was -$784.43K.
- MARKER THERAPEUTICS, INC. increase (decrease) in other receivables for the quarter ending 2025-03-31 was $112.06K.
- MARKER THERAPEUTICS, INC. increase (decrease) in other receivables for fiscal 2025 was -$977.30K, a 174.10% decline from fiscal 2024.
- MARKER THERAPEUTICS, INC. increase (decrease) in other receivables for fiscal 2024 was $1.32M.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|
| 2026-06-30 | $242.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $250.08K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $7.90K 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | -$977.30K 10-K · filed 2026-03-18 | ||
| 2025-06-30 | -$784.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$672.37K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $112.06K 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | $1.32M 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |